Advertisement
Organisation › Details
KeyNeurotek (Group)
https://www.keyneurotek.com
Link has been incorrect on 2011-10-18
KeyNeurotek Pharmaceuticals, a privately held biotechnology company, was founded in 2000 within the Magdeburg region in Germany, one of the leading centers of neuroscience in Europe. The company pursues a number of drug candidates in various preclinical and clinical stages. The most advanced compound, KN38-7271, is in clinical development for TBI and stroke. KeyNeurotek Pharmaceuticals has unique functional and tissue-based high throughput screening platforms for compatible ex vivo and in vivo studies (TELOMICSTM). Based on its know-how, KeyNeurotek develops innovative therapies for the treatment of various neurodegenerative diseases of the central nervous system, such as traumatic brain injury, stroke, Alzheimer's disease and urinary incontinence/overactive bladder. The company has built a strong network with renowned local and international partners, including, among others, the Leibniz Association, the Max Planck Society and Fraunhofer Society, Evotec, Schwarz Pharma/UCB, Bayer Schering and Gruenenthal. KeyNeurotek has been awarded the Hugo-Junckers Innovation Award of the State of Sachsen-Anhalt in 2002 and 2004 and the Innovation Award of the German Industry in 2006. *
Start | 2000-01-01 established | |
End | 2011-08-16 bankruptcy | |
Predecessor | University of Magdeburg | |
Industry | drug discovery technology | |
Region | Magdeburg | |
Country | Germany | |
Street | 44 Leipziger Str. ZENIT Technology Park | |
City | 39120 Magdeburg | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | B: 11 to 50 (2005-06-29) |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top